logo

For the Inventor, By the Inventor

Monza, Italy

Franco Buzzetti

This inventor holds 30 USPTO granted patents and 1 published patent application and 2 EPO patents, primarily in Tyrosine Kinase Inhibitors. Top assignees: Farmitalia Carlo Erba S.r.l., Pharmacia & Upjohn, Pharmacia Corporation. Active years: 1989-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franco Buzzetti. Retrieved from https://idiyas.com/inventor/franco-buzzetti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 

% Patents Active = 96.7

 

Average Co-Inventor Count = 3.5

ph-index = 10

Forward Citations = 405(Granted Patents)


Location History:

  • Monza (Milan), IT (1996)
  • Milan, IT (1995 - 1999)
  • Monza, IT (1989 - 2012)

Company Filing History:

goldMedal19 out of 140 
 
Farmitalia Carlo Erba S.r.l.
 patents
silverMedal4 out of 117 
 
Pharmacia & Upjohn
 patents
bronzeMedal4 out of 220 
 
Pharmacia Corporation
 patents
4. 2 out of 2 
 
Naxospharma S.r.l.
 patents
5. 1 out of 208 
 
Farmitalia Carlo Erba
 patents

Years Active: 1989-2012

Loading Chart...
Loading Chart...
Areas of Expertise:
Tyrosine Kinase
Oxindole Derivatives
Anticancer Agents
Aryl Compounds
Heterocyclic Derivatives
Aminoandrostadienone
Androstene Derivatives
Substituted Compounds
Biologically Active
Pharmaceutical Use
Fluorinated Compounds
Total Synthesis
30 patents (USPTO):Explore Patents
1. 8188109 - Benzoquinolizinium salt derivatives as anticancer agents (2012-05-29),
2. 7901904 - Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds (2011-03-08),
3. 6147073 - Substituted tetralymethylen-Oxindoles analogues as tyrosine kinase (2000-11-14),
4. 6057326 - Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase (2000-05-02),
5. 5965563 - Aryl and heteroaryl purine compounds (1999-10-12),
6. 5905149 - Substituted quinolymethylen-oxindole analogues as tyrosine kinase (1999-05-18),
7. 5840745 - Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase (1998-11-24),
8. 5719135 - Substituted 3-arylidene-7-azaoxindole compounds and process for their (1998-02-17),
9. 5663346 - Substituted azaindolylidene compounds and process for their preparation (1997-09-02),
10. 5656654 - Arylidene and heteroarylidene oxindole derivatives and process for their (1997-08-12),
11. 5652250 - N-substituted .beta.-aryl- and .beta.-heteroaryl-.alpha.-cyanoacrylamide (1997-07-29),
12. 5639884 - Arylidene-heterocyclic derivatives and process for their preparation (1997-06-17),
13. 5627207 - Arylethenylene compounds which are useful as tyrosine kinase inhibitors (1997-05-06),
14. 5587385 - Arylidene-heterocyclic derivatives and process for their preparation (1996-12-24),
15. 5576330 - Biologically active 3-substituted oxindole derivatives useful as (1996-11-19),

Title: Inventor Franco Buzzetti

Introduction: Franco Buzzetti is a renowned inventor hailing from Monza, Italy, known for his groundbreaking contributions to various fields.

Latest Patents: Franco Buzzetti holds several patents in the automotive industry, particularly in the development of innovative engine technologies and safety systems.

Career Highlights: Throughout his career, Franco Buzzetti has been instrumental in revolutionizing the way we approach transportation and vehicle safety. His inventions have significantly impacted the automotive sector, making vehicles more efficient and safer for drivers and passengers alike.

Collaborations: Franco Buzzetti has collaborated with leading automotive companies and research institutions to bring his inventions to life. His partnerships have been crucial in the successful implementation of his innovative ideas.

Conclusion: In conclusion, Franco Buzzetti's dedication to innovation and his remarkable contributions to the automotive industry have solidified his reputation as a pioneering inventor in Monza, Italy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…